Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 02 tags : Research save search
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
Published: 2021-08-02 (Crawled : 23:00) - globenewswire.com
MRVI 4 | $7.68 -0.52% -0.52% 1.3M
|
Commercial Services
|
| O: 0.41%
H: 8.09%
C: 7.24%
covid biotech vaccine research iot
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
PSNL | $1.3 -5.8% -6.15% 160K
|
Health Technology
|
| O: 0.62%
H: 0.71%
C: -1.47%
immunotherapy therapy cancer biomarkers
Grindrod Shipping Holdings Ltd CEO Live 1x1 Discussion with Jefferies Head of Maritime Research on “Deep Dive into GRIN and the Dry Bulk Sector” Webinar on Wednesday, August 4th at 11.00 am ET
Published: 2021-08-02 (Crawled : 16:00) - globenewswire.com
GRIN | $13.83 1.05% 8.8K
|
Transportation
|
| O: -1.38%
H: 3.26%
C: 1.49%
maritime ceo research
Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
Published: 2021-08-02 (Crawled : 14:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.36%
H: 0.75%
C: -0.18%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.21%
C: -0.12%
ARCT 4 | $27.0 -3.33% -3.44% 270K
|
Health Technology
|
| O: 6.36%
H: 9.92%
C: 5.16%
vaccine trial approval sars-cov-2
Sorrento Receives FDA Authorization to Start Phase 1 Clinical Trial of Proprietary, "Off-the-Shelf", Allogeneic anti-CD38 DAR-T (Dimeric Antigen Receptor-T) Cell Therapy to Treat Relapsed or Refractory Multiple Myeloma
Published: 2021-08-02 (Crawled : 14:00) - biospace.com/
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 1.71%
H: 1.8%
C: -0.12%
fda phase 1 therapy trial authorized t-cell
Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the American Society for Bone and Mineral Research Annual Meeting
Published: 2021-08-02 (Crawled : 13:15) - biospace.com/
ENTX | $2.07 -6.76% -7.25% 160K
|
Health Technology
|
| O: 5.4%
H: 2.66%
C: 1.71%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.37%
H: 0.15%
C: -0.96%
treatment phase 2 bone eb613 research osteoporosis
RESEARCH FRONTIERS TO HOST SECOND-QUARTER 2021 CONFERENCE CALL
Published: 2021-08-02 (Crawled : 13:00) - smartglass.com
REFR | $1.62 8.73% 8.02% 28K
|
Electronic Technology
|
| O: 12.12%
H: 4.63%
C: -5.02%
research conference
FDA Clears Vaxart's IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate
Published: 2021-08-02 (Crawled : 13:00) - biospace.com/
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 4.19%
H: 3.05%
C: -2.56%
covid fda vaccine fda clearance application covid-19
Avidity Biosciences Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA™ Trial of AOC 1001 in Adults with Myotonic Dystrophy (DM1)
Published: 2021-08-02 (Crawled : 13:00) - biospace.com/
RNA | News M | $25.105 -0.14% -0.14% 560K
|
Health Technology
|
| O: 0.76%
H: 5.74%
C: 4.3%
fda phase 1 trial clearance
Mustang Bio Receives European Medicines Agency PRIME Designation for MB-107 to Treat X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Published: 2021-08-02 (Crawled : 13:00) - biospace.com/
MBIO | $0.35 -2.7% -2.77% 120K
|
Health Technology
|
| O: 0.69%
H: 0.69%
C: -3.79%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 0.8%
H: 1.27%
C: 0.0%
europe primec designation
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Therapeutic
Published: 2021-08-02 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 3.82%
H: 1.56%
C: -3.72%
phase 1 phase 2 phase 3
89bio Completed Target Enrollment in Histology Cohort to Evaluate BIO89-100 for the Treatment of NASH- Study
Published: 2021-08-02 (Crawled : 13:00) - biospace.com/
ETNB | $8.59 -3.7% -3.84% 870K
|
Health Technology
|
| O: 3.19%
H: 8.46%
C: 5.74%
treatment nash enroll
Plastic Waste Management Market Size to Reach USD 40.80 Billion By 2027 | Implementation of Sustainable Development and Awareness Regarding Hazardous Effects of Plastic Waste are Significant Factors Influencing Industry Demand, says Emergen Research
Published: 2021-08-02 (Crawled : 12:00) - prnewswire.com
WM | News | $210.43 0.79% 0.0% 1.8M
|
Industrial Services
|
| O: 1.7%
H: 0.3%
C: -0.96%
WCN | $166.18 0.01% -0.03% 1.3M
|
Industrial Services
|
| O: 1.05%
H: 0.45%
C: -0.32%
research merge
Castle Biosciences Collaborates with the Melanoma Research Foundation
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
CSTL | $19.89 -0.85% -0.85% 84K
|
Health Technology
|
| O: 3.04%
H: 1.33%
C: -0.63%
research collaboration bioscience
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
OFIX | $13.57 2.65% 2.58% 290K
|
Health Technology
|
| O: 1.61%
H: 1.48%
C: -0.6%
implant ev
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca's anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.7%
H: 0.86%
C: 0.58%
fda fda approval research approval lupus
Esports Market Size to Reach USD 5,199.8 Million in 2028 | Increasing Number of Live Esports Coverage Platforms and Participants and Rising Popularity of Video Games are Some Key Factors Driving Industry Demand, says Emergen Research
Published: 2021-08-02 (Crawled : 11:00) - prnewswire.com
EA 4 | $128.17 0.81% 0.8% 1.5M
|
Consumer Durables
|
| O: 1.59%
H: 0.44%
C: -0.61%
ATVI | $94.42 0.13% 7.3M
|
Consumer Durables
|
| O: 0.92%
H: 0.16%
C: -1.51%
research merge
Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science
Published: 2021-08-02 (Crawled : 05:00) - globenewswire.com
ADXN | $18.74 -10.32% 12K
|
Health Technology
|
| O: -1.32%
H: 2.98%
C: -6.58%
drug research pharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.